Delayed stem cell therapy following heart attack is safe but not effective

Stem cells obtained from bone marrow, known as BMCs, can be safely injected into people two to three weeks following a heart attack, reports a new clinical trial. However, while safe, the BMCs did not improve heart function six months after their administration.

Read the whole article on Science Daily

More from Science Daily